SEARCH

SEARCH BY CITATION

References

  • Almeida M, Han L, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, Kousteni S, O’Brien CA, Bellido T, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC (2007a) Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J. Biol. Chem. 282, 2728527297.
  • Almeida M, Han L, Martin-Millan M, O’Brien CA, Manolagas SC (2007b) Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J. Biol. Chem. 282, 2729827305.
  • Almeida M, Ambrogini E, Han L, Manolagas SC, Jilka RL (2009) Increased lipid oxidation causes oxidative stress, increased PPAR{gamma} expression and diminished pro-osteogenic Wnt signaling in the skeleton. J. Biol. Chem. 284, 2743827448.
  • Ambrogini E, Almeida M, Martin-Millan M, Paik J-H, DePinho RA, Han L, Goellner J, Weinstein RS, Jilka RL, O‘Brien CA, Manolagas SC (2010) FoxO mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab, In press. DOI: 10.1016/j.cmet.2009.12.009.
  • Chen W-T, Shih TT, Chen R-C, Lo S-Y, Chou C-T, Lee J-M, Tu H-Y (2001) Vertebral bone marrow perfusion evaluated with dynamic contrast-enhanced MR imaging: significance of aging and sex. Radiology 220, 213218.
  • Cooper MS, Walker EA, Bland R, Fraser WD, Hewison M, Stewart PM (2000) Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone. Bone 27, 375381.
  • Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M, Stewart PM (2002) Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J. Bone Miner. Res. 17, 979986.
  • Dennison E, Hindmarsh P, Fall C, Kellingray S, Barker D, Phillips D, Cooper C (1999) Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men. J. Clin. Endocrinol. Metab. 84, 30583063.
  • Diederich S, Ekkehard E, Burkhardt P, Quinkler M, Bumke-Vogt C, Rochel M, Seidelmann D, Esperling P, Oelkers W, Bähr V (2002) 11β-hydroxysteriod dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids. J. Clin. Endocrinol. Metab. 87, 56955701.
  • Drescher W, Li H, Qvesel D, Jensen SD, Flo C, Hansen ES, Bünger C (2000) Vertebral blood flow and bone mineral density during long-term corticosteroid treatment: an experimental study in immature pigs. Spine 25, 30213025.
  • Gennari L, Bilezikian JP (2009) Glucocorticoid-induced osteoporosis: hope on the horizon. Lancet 373, 12251226.
  • Goans RE, Weiss GH, Abrams SA, Perez MD, Yergey AL (1995) Calcium tracer kinetics show decreased irreversible flow to bone in glucocorticoid treated patients. Calcif. Tissue Int. 56, 533535.
  • Gourion-Arsiquaud S, West PA, Boskey AL (2008) Fourier transform-infrared microspectroscopy and microscopic imaging. Methods Mol. Biol. 455, 293303.
  • Hui SL, Slemenda CW, Johnston CC (1988) Age and bone mass as predictors of fracture in a prospective study. J. Clin. Invest. 81, 18041809.
  • Ishijima H, Ishizaka H, Horikoshi H, Sakurai M (1996) Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging. Am. J. Roentgenol. 167, 355358.
  • Kanis JA, Johnell O, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int. 19, 385397.
  • Kita K, Kawai K, Hirohata K (1987) Changes in bone marrow blood flow with aging. J. Orthop. Res. 5, 569575.
  • Knothe Tate ML, Niederer P, Knothe U (1998) In vivo tracer transport through the lacunocanalicular system of rat bone in an environment devoid of mechanical loading. Bone 22, 107117.
  • Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O’Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC (2002) Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298, 843846.
  • Liebschner MAK, Keller TS (2005) Hydraulic strengthening affects the stiffness and strength of cortical bone. Ann. Biomed. Eng. 33, 2638.
  • Lien J, Kaye M (1978) Changes in the red cell, plasma, and inulin spaces and in the total water contents of rat femurs in cortisone induced osteoporosis. Calcif. Tissue Res. 25, 245248.
  • Manolagas SC (2000) Corticosteroids and fractures: a close encounter of the third cell kind. J. Bone Miner. Res. 15, 10011005.
  • Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr. Rev., In Press. DOI: 10.121/er.2009-0024.
  • Manolagas SC, Almeida M (2007) Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol. Endocrinol. 21, 26052614.
  • Miserez A, Schneberk T, Sun C, Zok FW, Waite JH (2008) The transition from stiff to compliant material in squid beaks. Science 319, 18161819.
  • Nalla RK, Balooch M, Ager JW, Kruzic JJ, Kinney JH, Ritchie RO (2005) Effects of polar solvents on the fracture resistance of dentin: role of water hydration. Acta Biomater. 1, 3143.
  • O’Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145, 18351841.
  • Parfitt AM (2000) The mechanism of coupling: a role for the vasculature. Bone 26, 319323.
  • Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, De Cabo R (2008) Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 8, 157168.
  • Peel NFA, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann. Rheum. Dis. 54, 801806.
  • Perzigian AJ (1973) Osteoporotic bone loss in two prehistoric Indian populations. Am. J. Phys. Anthropol. 39, 8795.
  • Plotkin LI, Weinstein RS, Parfitt AM, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J. Clin. Invest. 104, 13631374.
  • Prisby RD, Ramsey MW, Behnke BJ, Dominguez JM, Donato AJ, Allen MR, Delp MD (2007) Aging reduces skeletal blood flow, endothelium-dependent vasodilatation, and NO bioavailability in rats. J. Bone Miner. Res. 22, 12801288.
  • Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH (2004) Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J. Clin. Endocrinol. Metab. 89, 281287.
  • Reynolds RM, Dennison EM, Walker BR, Syddall HE, Wood PJ, Andrew R, Phillips DI, Cooper C (2005) Cortisol secretion and rate of bone loss in a population-based cohort of elderly men and women. Calcif. Tissue Int. 77, 134138.
  • Riggs BL, Khosla S, Melton LJ III (1998) A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J. Bone Miner. Res. 13, 763776.
  • Sandeep TC, Walker BR (2001) Pathophysiology of modulation of local glucocorticoid levels by 11β-hydroxysteroid dehydrogenases. Trends Endocrinol. Metab. 12, 446453.
  • SAS/STAT (2002) SAS Institute Inc., version 9.1. Cary, NC: SAS Institute Inc.
  • Seeman E (2006) Bone quality – the material and structural basis of bone strength and fragility. N. Engl. J. Med. 354, 22502261.
  • Sher LB, Woitge HW, Adams DJ, Gronowicz GA, Krozowski Z, Harrison JR, Kream BE (2004) Transgenic expression of 11β-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Endocrinology 145, 922929.
  • Small GR, Hadoke PWF, Sharif I, Dover AR, Armour D, Kenyon CJ, Gray GA, Walker BR (2005) Preventing local regeneration of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1 enhances angiogenesis. Proc. Natl Acad. Sci. USA 102, 1216512170.
  • Sonntag WE, Lynch CD, Cooney PT, Hutchins PM (1997) Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. Endocrinology 138, 35153520.
  • StatCorp (2005) Stata Statistical Software: Release 8.2. College Station, TX: Stata Corp.
  • Tatsuno I, Sugiyama T, Suzuki S, Yoshida T, Tanaka T, Sueishi M, Saito Y (2009) Age dependence of early symptomatic vertebral fracture with high-dose glucocorticoid treatment for collagen vascular diseases. J. Clin. Endocrinol. Metab. 94, 16711677.
  • Timmins PA, Wall JC (1977) Bone water. Calcif. Tissue Res. 23, 15.
  • Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM (2004) 11β-hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response. Endocr. Rev. 25, 831866.
  • Turner CH, Burr DB (1993) Basic biomechanical measurements of bone: a tutorial. Bone 14, 595608.
  • Van Cauter E, Leproult R, Kupfer DJ (1996) Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J. Clin. Endocrinol. Metab. 81, 24682473.
  • Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum. 48, 32243229.
  • Wang L, Wang Y, Han Y, Henderson SC, Majeska RJ, Weinbaum S, Schaffler MB (2005) In situ measurement of solute transport in the bone lacunar-canalicular system. Proc. Natl. Acad. Sci. U S A 102, 1191111916.
  • Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, Bouxsein ML, Faugere MC, Guldberg RE, Gerstenfeld LC, Haase VH, Johnson RS, Schipani E, Clemens TL (2007) The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J. Clin. Invest. 117, 16161626.
  • Weinstein RS (2000) Perspective: true strength. J. Bone Miner. Res. 15, 621625.
  • Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of the deleterious effects on bone. J. Clin. Invest. 102, 274282.
  • Wilkinson CW, Petrie EC, Murray SR, Colasurdo EA, Raskind MA, Peskind ER (2001) Human glucocorticoid feedback inhibitions reduced in older individuals: evening study. J. Clin. Endocrinol. Metab. 86, 545550.
  • Wilson EE, Awonusi A, Morris MD, Kohn DH, Tecklenburg MM, Beck LW (2006) Three structural roles for water in bone observed by solid-state NMR. Biophys. J. 90, 37223731.